# Ranata Therapeutics Ranata Therapeutics is an early-stage company that aims to build biologic therapies, antibodies or bispecifics, designed around the unique features of an individual patient's cancer cells. Author: Kevin Wimer Canonical URL: https://kevinwimer.com/companies/ranata-therapeutics/ Stable ID: 54968232-8247-41b0-818c-2fafca427249 Revision: e0e62860-c1be-4125-894f-c67672c1b265 Published: 2026-10-25T03:24:34.854Z Updated: 2026-10-25T03:24:34.854Z Reviewed: 2026-10-24 ## Who this is for For patients and caregivers who want to follow or ask about personalized antibody therapies for cancer. Inclusion is not a recommendation or a finding that this approach is right for your situation. Ranata Therapeutics is an early-stage company that wants to build biologic drugs, antibodies or bispecifics, against the features that make one patient's cancer cells unique. Its site describes the idea as medicines inspired by your biology, for you. It is part of the Even One Ventures portfolio, a group of companies started to make scientific advances reach patients faster. ## What it is working on Antibodies are proteins that bind to a specific target. Bispecifics bind two targets at once. Ranata's site says it is improving these binder-based biologics to better target a tumor, starting from what is distinctive about that person's cancer cells rather than a target shared across many patients. ## Where it stands This is early. As of October 24, 2026, the site does not list a clinical trial, a price, eligibility rules or a date when patients could receive a treatment. I would treat it as a company to follow and ask questions of, not a treatment you can sign up for today. ## How to start The site has an "Explore your options" section that invites you to email the company. Bring a short summary of your diagnosis, treatment history and any tumor testing reports if you reach out. ## How it fits Like [Echo Immune](/companies/echo-immune/) and [Serova](/companies/serova/), Ranata is working on treatment built around one patient's tumor. Those two make personalized vaccines; Ranata is working on antibodies. Approaches like this depend on detailed information about your tumor, so [Tumor testing](/resources/tumor-testing/) is a good place to start. [Clinical trials](/resources/clinical-trials/) and [Personalized cancer vaccines: what to ask](/resources/cancer-vaccines/) cover questions that apply here too. ## Questions I would ask 1. Is anything open to patients now, such as a study or an expanded access path? 2. What tumor testing would you need to find a target in my cancer? 3. How would my oncologist be involved? 4. How long would it take to go from my tumor data to a treatment? 5. What would it cost, and who would pay? ## Contacts - Website: [ranatatx.com](https://ranatatx.com/) - Email: [info@ranatatx.com](mailto:info@ranatatx.com) ## Limits and context Early stage. As of October 24, 2026, the company site does not describe a clinical trial, a price, eligibility or availability for patients. Details are as the company describes them. Talk with your oncologist before pursuing any experimental treatment. ## Relationships and disclosures I have no financial or business relationship with Ranata Therapeutics. ## Sources - [Ranata Therapeutics: home page](https://ranatatx.com/) — Ranata Therapeutics; official; checked 2026-10-24; Builds biologic therapies (antibodies or bispecifics) against the unique features of a patient's cancer cells; improving binder-based biologics to better target a tumor; contact by email. - [Even One Ventures: portfolio](https://evenone.ventures/) — Even One Ventures; official; checked 2026-10-24; Ranata Tx listed as an oncology company in the Even One Ventures portfolio. Organization website: https://ranatatx.com/ Organization type: Company Services: Research & development programs Community focus: People with any type of cancer, Caregivers Information/access: [Contact Ranata by email](https://ranatatx.com/) Service status: research ## Company facts - **Approach:** Antibodies or bispecifics designed around the unique features of one patient's cancer cells. (Sources: ranata-home) - **Stage:** Early stage. The site lists no clinical trial, price or availability as of October 24, 2026. (Sources: ranata-home) - **How to start:** Email the company through the contact on its site. (Sources: ranata-home) - **Backer:** Part of the Even One Ventures portfolio. (Sources: evenone-portfolio) Topics: emerging-research Capabilities: emerging-research Related record IDs: 9eec2ffb-1476-4c56-9915-51ec10135591, 45dd3750-3fe0-4621-9723-fc49fdeaffc2, f7221927-6b87-4be3-9a7c-906768a192a5, bcbf518f-872e-434c-b031-3d6c266ceaa4, 966ad3d5-e20a-40de-ba3d-cb072e57ebef Follow Kevin on X: https://x.com/kevinace Educational information, not an individualized treatment recommendation.